Thryvv : ratio page

Ipca Laboratories

Overview Articles News Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2024
Mar2023
Mar2022
Mar2021
Mar2020
Valuation Parameters:
PE(x)
57.39
43.62
30.45
10.59
14.46
PCE(x)
35.44
27.28
23.55
17.77
21.54
Price/Book(x)
4.96
3.52
4.93
5.13
4.85
Yield(%)
0.32
0.49
0.38
0.42
0.36
EV/Net Sales(x)
4.24
3.25
4.67
4.45
3.86
EV/Core EBITDA(x)
22.44
19.11
19.63
14.92
18.26
EV/EBIT(x)
33.05
25.41
23.60
17.14
23.51
EV/CE(x)
4.21
2.76
4.33
3.96
3.39
MCap / Sales
4.10
3.31
4.64
4.47
3.80
Growth Ratio:
Net Sales Growth(%)
23.50
7.03
7.45
16.80
23.32
Core EBITDA Growth(%)
37.28
-23.51
-14.35
64.84
29.76
EBIT Growth(%)
23.94
-30.82
-18.15
84.70
33.40
PAT Growth(%)
7.58
-46.00
-20.71
90.34
36.48
EPS Growth(%)
16.13
-46.69
-61.22
87.28
36.07
Financial Stability Ratios:
Total Debt/Equity(x)
0.22
0.25
0.14
0.05
0.13
Current Ratio(x)
2.35
2.87
3.03
2.96
2.15
Quick Ratio(x)
1.30
1.91
1.77
1.59
1.16
Interest Cover(x)
6.99
16.47
102.40
114.20
38.37
Total Debt/Mcap(x)
0.04
0.07
0.03
0.01
0.03
Operational & Financial Ratios:
Earnings Per Share (Rs)
21.57
18.58
34.85
89.87
47.99
CEPS(Rs)
34.94
29.70
45.07
53.53
32.21
DPS(Rs)
4.00
4.00
4.00
8.00
5.00
Book NAV/Share(Rs)
249.53
230.27
215.41
370.65
286.15
Tax Rate(%)
37.20
33.99
19.79
17.29
18.32
Margin Ratios:
Core EBITDA Margin(%)
16.41
14.47
21.57
27.33
19.16
EBIT Margin(%)
12.76
12.71
19.67
25.85
16.32
Pre Tax Margin(%)
10.94
11.94
19.48
25.63
15.89
PAT Margin (%)
6.87
7.88
15.63
21.20
12.98
Cash Profit Margin (%)
11.50
12.07
19.61
25.06
17.51
Performance Ratios:
ROA(%)
5.37
6.06
13.31
20.29
12.31
ROE(%)
8.70
8.70
17.92
27.63
17.92
ROCE(%)
13.10
11.71
20.46
30.92
19.71
Asset Turnover(x)
0.78
0.77
0.85
0.96
0.95
Sales/Fixed Asset(x)
1.35
1.54
1.68
1.75
1.65
Working Capital/Sales(x)
2.42
1.85
1.96
2.38
3.04
Efficiency Ratios:
Fixed Capital/Sales(x)
0.74
0.65
0.60
0.57
0.60
Receivable days
63.37
55.52
53.92
57.48
61.90
Inventory Days
99.83
105.25
108.09
98.25
94.05
Payable days
100.50
86.04
111.16
136.39
128.13